{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T08:45:18Z","timestamp":1776933918673,"version":"3.51.2"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,1,26]],"date-time":"2016-01-26T00:00:00Z","timestamp":1453766400000},"content-version":"vor","delay-in-days":1395,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the Formosan Medical Association"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.jfma.2011.04.004","type":"journal-article","created":{"date-parts":[[2012,3,23]],"date-time":"2012-03-23T07:02:00Z","timestamp":1332486120000},"page":"201-208","source":"Crossref","is-referenced-by-count":38,"title":["Impact of increasing alanine aminotransferase levels within normal range on incident diabetes"],"prefix":"10.1016","volume":"111","author":[{"given":"Chong-Shan","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting-Tsung","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Jen","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shan-Tair","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pesus","family":"Chou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfma.2011.04.004_bib1","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/414782a","article-title":"Global and societal implications of the diabetes epidemic","volume":"414","author":"Zimmet","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.jfma.2011.04.004_bib2","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1056\/NEJMp038239","article-title":"Causation of type 2 diabetes\u2014the Gordian knot unravels","volume":"350","author":"Taylor","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2011.04.004_bib3","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/S0140-6736(06)69703-1","article-title":"Epidemic obesity and type 2 diabetes in Asia","volume":"368","author":"Yoon","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.jfma.2011.04.004_bib4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1146\/annurev.publhealth.26.021304.144532","article-title":"Primary prevention of diabetes: what can be done and how much can be prevented?","volume":"26","author":"Schulze","year":"2005","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/j.jfma.2011.04.004_bib5","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2337\/diabetes.53.3.693","article-title":"Inflammatory markers and risk of developing type 2 diabetes in women","volume":"53","author":"Hu","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.jfma.2011.04.004_bib6","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1001\/jama.291.16.1978","article-title":"Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus","volume":"291","author":"Meigs","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.jfma.2011.04.004_bib7","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1053\/j.gastro.2004.12.004","article-title":"Contribution of metabolic factors to alanine aminotransferase activity in persons with other causes of liver disease","volume":"128","author":"Ioannou","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jfma.2011.04.004_bib8","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1002\/hep.20973","article-title":"Nonalcoholic fatty liver disease: from steatosis to cirrhosis","volume":"43","author":"Farrell","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jfma.2011.04.004_bib9","doi-asserted-by":"crossref","first-page":"2855","DOI":"10.2337\/diabetes.53.11.2855","article-title":"Elevated alanine aminotransferase predicts new-onset type 2 diabetes independently of classical risk factors, metabolic syndrome, and C-reactive protein in the west of Scotland coronary prevention study","volume":"53","author":"Sattar","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.jfma.2011.04.004_bib10","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.2337\/diabetes.51.6.1889","article-title":"High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes","volume":"51","author":"Vozarova","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.jfma.2011.04.004_bib11","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.2337\/diacare.28.12.2913","article-title":"Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men","volume":"28","author":"Wannamethee","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jfma.2011.04.004_bib12","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.2337\/diabetes.53.10.2623","article-title":"Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study","volume":"53","author":"Hanley","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.jfma.2011.04.004_bib13","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.2337\/dc07-2159","article-title":"Liver enzymes and incident diabetes: findings from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study","volume":"31","author":"Ford","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jfma.2011.04.004_bib14","doi-asserted-by":"crossref","first-page":"2812","DOI":"10.2337\/diacare.28.11.2812","article-title":"No independent association of alanine aminotransferase with risk of future type 2 diabetes in the Hoorn study [letter]","volume":"28","author":"Schindhelm","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jfma.2011.04.004_bib15","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.2337\/diacare.28.7.1757","article-title":"Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study","volume":"28","author":"Nannipieri","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jfma.2011.04.004_bib16","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S1262-3636(07)70229-X","article-title":"Hepatic markers and development of type 2 diabetes in middle aged men and women: a three-year follow-up study. The D.E.S.I.R. Study","volume":"31","author":"Andre","year":"2005","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.jfma.2011.04.004_bib17","doi-asserted-by":"crossref","first-page":"389","DOI":"10.4269\/ajtmh.2002.66.389","article-title":"Comparison of HBV and HCV prevalence and risk factors in a community-based study","volume":"66","author":"Wang","year":"2002","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.jfma.2011.04.004_bib18","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/aje\/kwm061","article-title":"Infection and the development of type 2 diabetes","volume":"166","author":"Wang","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jfma.2011.04.004_bib19","series-title":"Equity, social determinants and public health programmes","article-title":"Diabetes: equity and social determinants","author":"Whiting","year":"2010"},{"key":"10.1016\/j.jfma.2011.04.004_bib20","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.metabol.2005.05.027","article-title":"Hyperinsulinemia predicts hepatic fat content in healthy individuals with normal transaminase concentrations","volume":"54","author":"Ardigo","year":"2005","journal-title":"Metabolism"},{"key":"10.1016\/j.jfma.2011.04.004_bib21","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1001\/archinte.164.19.2169","article-title":"Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults","volume":"164","author":"Kim","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jfma.2011.04.004_bib22","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.2337\/diabetes.54.11.3140","article-title":"Liver markers and development of the metabolic syndrome: the insulin resistance atherosclerosis study","volume":"54","author":"Hanley","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.jfma.2011.04.004_bib23","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1001\/jama.2009.726","article-title":"Diabetes in Asia: epidemiology, risk factors, and pathophysiology","volume":"301","author":"Chan","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.jfma.2011.04.004_bib24","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jfma.2011.04.004_bib25","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2337\/diabetes.54.3.603","article-title":"Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes","volume":"54","author":"Petersen","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.jfma.2011.04.004_bib26","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1016\/j.jhep.2005.06.008","article-title":"Effect of changes on body weight and lifestyle in nonalcoholic fatty liver disease","volume":"43","author":"Suzuki","year":"2005","journal-title":"J Hepatol"},{"key":"10.1016\/j.jfma.2011.04.004_bib27","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.2337\/dc06-2169","article-title":"Serum alanine aminotransferase levels decrease further with carbohydrate than fat restriction in insulin-resistant adults","volume":"30","author":"Ryan","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jfma.2011.04.004_bib28","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1007\/s00125-006-0314-4","article-title":"Increasing incidence of diagnosed T2D in Taiwan: analysis of data from a national cohort","volume":"49","author":"Tseng","year":"2006","journal-title":"Diabetologia"}],"container-title":["Journal of the Formosan Medical Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092966461200040X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S092966461200040X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,25]],"date-time":"2018-11-25T01:20:38Z","timestamp":1543108838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S092966461200040X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S092966461200040X"],"URL":"https:\/\/doi.org\/10.1016\/j.jfma.2011.04.004","relation":{},"ISSN":["0929-6646"],"issn-type":[{"value":"0929-6646","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}